# Capsule Corporation Startup profile on Capital Atlas: https://capitalatlas.ai/startups/capsule - Industry: Internet - Headquarters: New York, US - Website: www.capsule.com/ - Total disclosed funding: $518M - Latest round: Series D (Apr 28, 2021) - Investors on record: 21 ## About Capsule Corporation, based in the US, operates as a digital pharmacy, simplifying prescription fulfillment for patients by delivering medications directly to homes and facilitating communication with healthcare providers.Capsule Corporation, founded in 2016 in New York, US, acts as a digital pharmacy that enhances the prescription process. The company has secured a total of USD 300.00 mn in funding, with its latest financing round being a SERIES D, led by Durable Capital Partners on December 31, 2022. Capsule has completed five deals to date. The founders, Joseph Jorgensen and Matthew Wilson, have backgrounds in tech and healthcare, contributing to the firm’s growth and innovative approach.Capsule operates as a digital pharmacy that streamlines the prescription fulfillment process for consumers. Its core offerings include the coordination of prescription transfers from existing pharmacies and direct communication with healthcare providers, enabling a seamless experience for patients. The service focuses on delivering medications directly to customers' homes, with free same-day delivery and insurance integration, ensuring that users only pay their standard copay without any additional fees. Capsule serves a diverse clientele that includes individuals with commercial insurance plans, Managed Medicaid, and Medicare Part D. The company's services are designed to cater to urban markets with a significant emphasis on convenience and accessibility, allowing users to manage their prescriptions through text and email communications.Capsule's revenue model is primarily structured around the acceptance of insurance copays for medications, thus aligning its financial success with the volume of prescriptions filled and delivered. The company facilitates transactions directly with consumers, allowing them to transfer prescriptions and receive medications without additional service fees. Through partnerships with various insurance providers, Capsule ensures that users have a straightforward experience with their healthcare expenses, only needing to cover their copay. As the firm operates in the competitive pharmacy sector, its revenue generation is heavily influenced by its ability to attract and retain customers through its technology-driven service offerings, which includes the innovative, user-friendly platform that supports prescription management and delivery.Capsule Corporation plans to utilize the recent funding raised in December 2022 to expand its services and enhance its technology. This includes the development of new product features aimed at improving user experience and increasing efficiency in prescription management. The company is exploring opportunities for expansion into additional urban markets across the US in the coming years, focusing on areas where access to traditional pharmacy services is limited. The aim is to broaden their reach and provide enhanced convenience to a larger customer base. ## Funding rounds - Series D, Apr 28, 2021, $300M — T Rowe Price, Baillie Gifford, Whale Rock Capital Partners, Durable Capital Partners - Series C, Jul 24, 2019, $153M — TCV, Thrive Capital, Global Founders Capital, Proton Enterprises, Glade Brook Capital Partners, M13, 7GC, Proaltus Capital Partners, University Growth Fund, FG2 Capital - Series B, Apr 9, 2018, $50M — TriplePoint Capital, Thrive Capital, G Squared, Glade Brook Capital Partners, Palm Drive Capital, Teamworthy Group, Reshape Holdings, 7GC - Series A, Nov 16, 2016, $14M — Virgin.com Limited, Thrive Capital, Global Founders Capital, Sound Ventures, Palm Drive Capital ## Investors - Virgin.com Limited — Series A - Thrive Capital (https://capitalatlas.ai/funds/thrive-capital) — Series A, Series B, Series C - Global Founders Capital (https://capitalatlas.ai/funds/global-founders-capital) — Series A, Series C - Sound Ventures (https://capitalatlas.ai/funds/sound-ventures) — Series A - Palm Drive Capital (https://capitalatlas.ai/funds/palm-drive-capital) — Series A, Series B - TriplePoint Capital (https://capitalatlas.ai/funds/triplepoint-capital) — Series B - G Squared (https://capitalatlas.ai/funds/g-squared) — Series B - Glade Brook Capital Partners (https://capitalatlas.ai/funds/glade-brook-capital-partners) — Series B, Series C - Teamworthy Group (https://capitalatlas.ai/funds/teamworthy-group) — Series B - Reshape Holdings (https://capitalatlas.ai/funds/reshape-holdings) — Series B - 7GC (https://capitalatlas.ai/funds/7gc) — Series B, Series C - TCV (https://capitalatlas.ai/funds/tcv) — Series C - Proton Enterprises (https://capitalatlas.ai/funds/proton-enterprises) — Series C - M13 (https://capitalatlas.ai/funds/m13) — Series C - Proaltus Capital Partners — Series C - University Growth Fund (https://capitalatlas.ai/funds/university-growth-fund) — Series C - FG2 Capital (https://capitalatlas.ai/funds/fg2-capital) — Series C - T Rowe Price (https://capitalatlas.ai/funds/t-rowe-price) — Series D - Baillie Gifford (https://capitalatlas.ai/funds/baillie-gifford) — Series D - Whale Rock Capital Partners — Series D - Durable Capital Partners — Series D